Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT00752518
Status:
COMPLETED
Last Update Posted:
2011-05-17
First Post:
2008-09-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-11
First Submit QC Date:
None
Study First Post Date:
2008-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-16
Last Update Post Date:
2011-05-17
Last Update Post Date Type:
ESTIMATED